Higher tech: Pittsburgh’s Cognistx using AI to identify psychedelic drugs to treat depression, anxiety and PTSD
They’re working with Canadian biotech firm MagicMed to develop PsyAI, a platform that aims to streamline pharmaceutical design and accelerate the modernization of psychedelic medicine.
05 May 2021